Skip to main content
Gloved hand administering Obsidio Conformable Embolic.

Obsidio™ Conformable Embolic


Obsidio First-in-Human Clinical Study: evaluation of Obsidio Embolic safety and performance

Overview – A single-center study* sought to evaluate the safety and performance of Obsidio Conformable Embolic (OCE) in patients requiring vascular embolization for hypervascular renal tumors.

Objectives – The study sought to demonstrate that Obsidio Embolic could be delivered safely, occludes the artery where deposited without migration, and does not lead to a change in standard blood tests.

Results – Obsidio Embolic achieved the absence of flow in the blood vessels of tumors, with embolization demonstrated to be durable without migration at Day 7.

1 MB
Download Obsidio paper
Medical scans showing arteries before and after with Obsidio, delivery achieving absence of flow in the blood vessel of tumor and no migration of Obsidio Embolic (Day 7).

Pre-clinical embolization procedure with Obsidio Conformable Embolic

View the deployment of Obsidio Embolic in the Left Renal Artery. 

document icon with purple arrow pointing up.

Submit your Obsidio case

* Obsidio Conformable Embolic Performance Testing